Irritable Bowel Syndrome (IBS) Treatment Market is set to hit US$ 7.60 billion growing at CAGR of 8.4% from forecast period 2024 to 2032 | PMR

𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 (𝐈𝐁𝐒) 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐜𝐞𝐧𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐭𝐡𝐞 "𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 (𝐈𝐁𝐒) 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧 (𝐈𝐁𝐒-𝐃𝐢𝐚𝐫𝐫𝐡𝐨𝐞𝐚, 𝐈𝐁𝐒-𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧, 𝐈𝐁𝐒-𝐌𝐢𝐱𝐞𝐝), 𝐃𝐫𝐮𝐠 𝐓𝐲𝐩𝐞, 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥, 𝐑𝐞𝐠𝐢𝐨𝐧- 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟑𝟐" 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐟𝐨𝐫 𝐢𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐛𝐨𝐰𝐞𝐥 𝐬𝐲𝐧𝐝𝐫𝐨𝐦𝐞 (𝐈𝐁𝐒) 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟑.𝟔𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟕.𝟔𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟒% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐.

Treatment of IBS concentrates on mitigating indicators so that one can reside as symptom-liberated as feasible. Gentle symptoms can frequently be regulated by handling stress and by rendering alterations in the diet and lifestyle. One must circumvent the foods that activate symptoms, consume high-fiber food, drink ample fluids, work out often, and get adequate sleep. The healthcare donor may recommend that one discard from the diet high in gas foods. This indicates that if one is encountering bloating or gas, one might circumvent items such as carbonated and alcoholic drinks and specific foods that might cause escalated gas.

𝐀𝐬𝐤 𝐔𝐬 𝐭𝐨 𝐆𝐞𝐭 𝐘𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.polarismarketresearch.com/industry-analysis/irritable-bowel-syndrome-ibs-treatment-market/request-for-sample

The initiation of several pipeline drugs to cure irritable bowel syndrome is expected to be a notable growth driver for the IBS treatment market during the forecast period. Stress measures connected with altering lifestyles are also anticipated to rise as people with IBS possess a colon that is sensitive to specific foods and stress.

𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
• Astellas Pharma Inc
• GlaxoSmithKline Plc
• Abbott Laboratories
• Takeda Pharmaceutical Company Ltd
• Johnson & Johnson
• Novartis AG
• AstraZeneca plc
• Sebela Pharmaceuticals Inc
• Synthetic Biologics
• Inc
• Bausch Health
• Synergy Pharmaceuticals Inc.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/1968/2

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
• The market analysis for irritable bowel syndrome (IBS) treatment is essentially founded on medical conditions, drug types, distribution channels, and regions.
• By medical condition, IBS with diarrhea witnessed a sharp rise owing to a rise in gastrointestinal diseases involving constipation and diarrhea due to altering lifestyles.
• By drug, the rifaximin segment dominated the irritable bowel syndrome (IBS) treatment market due to the escalation in the geriatric population and increasing pervasiveness of irritable bowel syndrome and improved diagnosis.

𝐁𝐲 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧 :
• IBS - Diarrhea
• IBS - Constipation
• IBS - Mixed
𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 :
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 (𝐈𝐁𝐒) 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• IBS - Diarrhea segment accounted for a maximum share in 2022. Increasing the number of patients in men and women is expected to boost the market.
• In addition, IBS- constipation held a significant revenue share due to increased demand for medications to treat both conditions.
• The drug type rifaximin segment is anticipated to have a high growth rate during the forecast period due to the rising prevalence of IBS and the development of advanced technological products.
• The Linaclotide drug type segment is expected to witness the highest CAGR over the anticipated period due to the development and production of the generic version of linaclotide.
• North America dominates the global irritable bowel syndrome industry due to increasing awareness of the condition and increasing the presence of competitors globally.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 :
𝗩𝗲𝘀𝘀𝗲𝗹 𝗦𝗲𝗮𝗹𝗶𝗻𝗴 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/vessel-sealing-devices-market
𝗖𝗹𝗲𝗮𝗿 𝗔𝗹𝗶𝗴𝗻𝗲𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/clear-aligner-market
𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝗽𝗮 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/medical-spa-market
𝗔𝘁𝘁𝗲𝗻𝘁𝗶𝗼𝗻 𝗗𝗲𝗳𝗶𝗰𝗶𝘁 𝗛𝘆𝗽𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/attention-deficit-hyperactivity-disorder-market
𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗟𝗶𝗾𝘂𝗶𝗱 𝗛𝗮𝗻𝗱𝗹𝗶𝗻𝗴 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/automated-liquid-handling-technologies-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.